DDX41 and viral infectious disease: In this case, while the protection rate was shown to be proportional to the level of cross-reactive Abs produced in the URT [63], the reduced level of the cross-reactive Abs evidently resulted in a decline in the efficiency of protection against heterologous virus infection [64].